A safety estimand for late phase clinical trials where the analysis period varies over the subjects.
Background/Aims: Evaluating safety is as important as evaluating efficacy in a clinical trial, yet the tradition for safety analysis is rudimentary. This article explores more complex methodologies for safety evaluation, with the aim of improving the interpretability, as well as generalizability, of...
| Publicado en: | Clinical Trials Vol. 21; no. 4; pp. 483 - 491 |
|---|---|
| Autores principales: | , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Sage Publications, Ltd.
Aug2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |